Dr. Rodrigo F Endara , MD
Physician • Chicago, IL
1417 N Ashland Ave
Chicago, IL 606222224
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on August 13, 2006; this date does not establish years in practice.
-
Published CMS data list 351 Original Medicare Part B services in 2019.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019. Published rows only; this is not a quality measure.
-
Published Part B service records, 2019:
- 99213 — Established patient outpatient office visit: 287 service units.
- 82947 — Blood glucose (sugar) level: 32 service units.
- 99214 — Established patient outpatient office visit: 19 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2018 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2019). CPT notice
See all 4 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,225 Medicare Part D prescriptions, including refills, in 2019.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2019. Published rows only; this is not a quality measure.
-
Published Part D records, 2019:
- Metformin Hcl — 95 prescription fills, including refills.
- Atorvastatin Calcium — 90 prescription fills, including refills.
- Omeprazole — 69 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2019. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 48 records in the table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part B services went from 1,037 in 2017 to 351 in 2019.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2017–2019.
Practice Location & Contact Primary Location
1417 N Ashland Ave
Chicago, IL 606222224
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Physician: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
75 people with Original Medicare in 2019
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2019.
Medicare-allowed amount
About $24,690 in 2019
The total amount Medicare approved for these services in 2019. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019.
Paid by Medicare
About $15,099 in 2019
The part of the Medicare-allowed amount that Medicare itself paid in 2019, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019.
30-day fills
1,948 standardized 30-day fills in 2019
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$75,309 in 2019
The total cost of these prescriptions in 2019, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2019.
Open Payments general payments, program year 2019
All general payments: $261.80 across 19 records.
By nature of payment
- Food and Beverage: $257.07 across 18 records.
- Education: $4.73 across 1 record.
Reporting-company totals (3 largest of 6)
- Novo Nordisk Inc: $109.58 across 10 records.
- GlaxoSmithKline, LLC.: $48.25 across 2 records.
- AstraZeneca Pharmaceuticals LP: $45.89 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2019 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 66% from 1,037 in 2017 to 351 in 2019.
- 2017: 1,037
- 2018: 619
- 2019: 351
-
Medicare-allowed amount
Medicare-allowed amount decreased 54% from $53,132 in 2017 to $24,690 in 2019.
- 2017: $53,132
- 2018: $42,231
- 2019: $24,690
-
Paid by Medicare
Paid by Medicare decreased 55% from $33,669 in 2017 to $15,099 in 2019.
- 2017: $33,669
- 2018: $27,488
- 2019: $15,099
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 54% from 2,638 in 2015 to 1,225 in 2019.
- 2015: 2,638
- 2016: 2,595
- 2017: 2,521
- 2018: 2,437
- 2019: 1,225
-
30-day fills
30-day fills decreased 37% from 3,082 in 2015 to 1,948 in 2019.
- 2015: 3,082
- 2016: 3,038
- 2017: 3,257
- 2018: 3,351
- 2019: 1,948
-
Part D drug cost
Part D drug cost decreased 41% from $128,606 in 2015 to $75,309 in 2019.
- 2015: $128,606
- 2016: $136,546
- 2017: $125,317
- 2018: $149,395
- 2019: $75,309
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2019 only.
Sources: CMS Medicare Physician & Other Practitioners (2019), CMS Medicare Part D Prescribers (2019), CMS Open Payments (2019), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2019 (payments made January 1 – December 31, 2019): 19 records totaling $261.80.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
BEXSERO | General | $24.98 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $24.94 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
BEXSERO | General | $23.27 |
| Ironwood Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
Linzess | General | $20.15 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $19.98 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $18.50 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $18.20 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $16.67 |
| ARBOR PHARMACEUTICALS, INC. |
Food and Beverage
In-kind items and services
|
Edarbyclor | General | $14.87 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Tresiba | General | $12.14 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
TOUJEO | General | $11.93 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
TOUJEO | General | $11.13 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $11.02 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Tresiba | General | $10.55 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Tresiba | General | $8.44 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $5.81 |
| Novo Nordisk Inc |
Education
In-kind items and services
|
Ozempic | General | $4.73 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $3.71 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $0.78 |
Source: CMS Open Payments, program year 2019, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2018 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2019; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
287 | 75 | $160.00 | $76.12 |
|
82947
Blood glucose (sugar) level
|
32 | 14 | $6.69 | $4.15 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
19 | 14 | $230.00 | $111.15 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
13 | 11 | $100.00 | $46.06 |
Source: CMS Part B by Provider and Service, 2019; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2019.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Metformin Hcl | Metformin Hcl | 95 | 5,880 | $716.09 | 31 |
| Atorvastatin Calcium | Atorvastatin Calcium | 90 | 6,060 | $1,367.89 | 39 |
| Omeprazole | Omeprazole | 69 | 3,390 | $1,037.34 | 29 |
| Carvedilol | Carvedilol | 56 | 2,460 | $284.35 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 50 | 1,732 | $707.89 | 26 |
| Enalapril Maleate | Enalapril Maleate | 49 | 2,331 | $1,149.43 | 11 |
| Levothyroxine Sodium | Levothyroxine Sodium | 47 | 2,880 | $777.42 | 13 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 41 | 2,730 | $1,867.99 | 21 |
| Metoprolol Succinate | Metoprolol Succinate | 39 | 2,100 | $836.50 | — |
| Tamsulosin Hcl | Tamsulosin Hcl | 39 | 2,430 | $652.43 | 13 |
| Ibuprofen | Ibuprofen | 33 | 912 | $282.89 | 13 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 33 | 1,167 | $15,042.43 | — |
| Azithromycin | Azithromycin | 28 | 139 | $196.45 | 24 |
| Alprazolam | Alprazolam | 26 | 415 | $103.09 | 14 |
| Ranitidine Hcl | Ranitidine Hcl | 26 | 997 | $541.73 | 13 |
| Telmisartan | Telmisartan | 26 | 840 | $733.32 | — |
| Amlodipine Besylate | Amlodipine Besylate | 25 | 1,230 | $139.04 | — |
| Levemir Flextouch | Insulin Detemir | 23 | 867 | $14,641.07 | — |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 23 | 1,170 | $3,859.30 | — |
| Nystatin | Nystatin | 22 | 356 | $442.71 | 15 |
| Losartan Potassium | Losartan Potassium | 19 | 900 | $114.68 | — |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 19 | 334 | $148.93 | 12 |
| Lisinopril | Lisinopril | 18 | 1,242 | $101.27 | — |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | 540 | $6,276.10 | — |
| Dexilant | Dexlansoprazole | 17 | 870 | $8,488.86 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2019; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 261QP2300X
Career & Practice History
NPI enumerated August 13, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Mailing Address
1417 N Ashland Ave
Chicago, IL 606222224
Phone: 7733421090